Medifast Expects Q2 Revenue Of $150M-$170M (Est $175.10M), EPS Of $0.05-$0.40 (Est $0.67)

Medifast, Inc. -2.28% Post

Medifast, Inc.

MED

24.43

24.43

-2.28%

0.00% Post

The EPS range excludes the costs related to the initiation of the LifeMD collaboration and any gains or losses from changes in the market price of the company's LifeMD common stock investment.

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via